The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult ...

A nasal spray flu vaccine for people up to 49 will be available for home use starting in the fall of 2025 after the Food and ...

The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...

The spray could be an alternative for people who are averse to getting injections, or otherwise find it difficult or ...

I love being able to go to the pharmacy for my own (or my kids’) flu shots. Pop in, get the shot, then go about my day. That ...

· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist ...

FluMist is the only nasal flu vaccine, but it is not new. The FDA approved it in 2003 for people 5 to 49 years old before ...

In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.

The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...

Sept. 23, 2024 – The FDA on Friday approved FluMist, a nasal spray flu vaccine that you or a caregiver can now give at home – no health care provider needed. It’s the first flu vaccine of its kind, ...

The FluMist vaccine can now be self-administered after the FDA approved its use to treat the influenza disease.

The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a ...